001367 海森药业
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额177,454167,15680,61574,949107,039
投资活动产生之现金流量净额(297,245)(61,748)(56,998)(21,178)(34,520)
筹资活动产生之现金流量净额(15,594)(10,391)673,328(3,766)(18,712)
汇率变动对现金及现金等价物的影响9132,6766055,519(1,458)
现金及现金等价物净增加/(减少)(134,473)97,694697,55055,52552,349
期初现金及现金等价物余额1,034,482936,788239,238183,714131,364
期末现金及现金等价物余额900,0091,034,482936,788239,238183,714